Why not?
By then they should have 2 drugs in market with U$3B revenue at 90% margins and another $10B one close...plus any others added in the interim. $12B at 90% = $10.8B net revenue - less overheads (relatively minor) and at say 10x PE would give the co a market cap of circa $108B.
OK, so all may not make it, revenue might not be as much as advertised, risks need to be factored in etc....but no doubt the potential is there and $35B is around 1/3 of that potential.
So, again, why not?
Why not?By then they should have 2 drugs in market with U$3B...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $38.24K | 348.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1010894 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 302957 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |